Stonegate Investment Group LLC Boosts Stock Holdings in The Allstate Co. (NYSE:ALL)

Stonegate Investment Group LLC raised its position in The Allstate Co. (NYSE:ALL) by 5.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,554 shares of the insurance provider’s stock after buying an additional 139 shares during the quarter. Stonegate Investment Group LLC’s holdings in Allstate were worth $492,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ALL. State Street Corp increased its stake in shares of Allstate by 1.1% in the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock worth $2,190,758,000 after purchasing an additional 126,922 shares in the last quarter. Geode Capital Management LLC grew its stake in Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock valued at $1,178,164,000 after buying an additional 74,537 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after acquiring an additional 472,040 shares during the period. Raymond James & Associates lifted its position in shares of Allstate by 10.6% during the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock worth $287,851,000 after acquiring an additional 145,986 shares in the last quarter. Finally, Pathway Financial Advisers LLC boosted its holdings in shares of Allstate by 18,472.5% in the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Price Performance

ALL stock opened at $191.21 on Wednesday. The firm has a market cap of $50.63 billion, a P/E ratio of 12.38, a P/E/G ratio of 1.41 and a beta of 0.52. The firm’s fifty day moving average is $194.56 and its 200 day moving average is $187.88. The Allstate Co. has a 52 week low of $153.42 and a 52 week high of $209.88. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same period last year, the firm earned $0.81 earnings per share. The company’s revenue for the quarter was up 14.7% compared to the same quarter last year. Research analysts predict that The Allstate Co. will post 16.83 earnings per share for the current year.

Allstate Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were given a $0.92 dividend. The ex-dividend date was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.92%. Allstate’s payout ratio is currently 23.83%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Barclays dropped their price objective on Allstate from $187.00 to $183.00 and set an “underweight” rating on the stock in a report on Monday, January 6th. BMO Capital Markets raised their price objective on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. UBS Group upped their target price on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Keefe, Bruyette & Woods raised their price target on shares of Allstate from $235.00 to $243.00 and gave the company an “outperform” rating in a report on Friday, January 10th. Finally, Wells Fargo & Company upped their price target on shares of Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $218.13.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.